| Literature DB >> 12890293 |
Brita Elvevåg1, Elizabeth A Maylor, Abigail L Gilbert.
Abstract
BACKGROUND: Prospective memory (PM), the act of remembering that something has to be done in the future without any explicit prompting to recall, provides a useful framework with which to examine problems in internal-source monitoring. This is because it requires distinguishing between two internally-generated processes, namely the intention to perform an action versus actual performance of the action. In habitual tasks, such as taking medicine every few hours, the same PM task is performed regularly and thus it is essential that the individual is able to distinguish thoughts (i.e., thinking about taking the medicine) from actions (i.e., actually taking the medicine).Entities:
Mesh:
Year: 2003 PMID: 12890293 PMCID: PMC184442 DOI: 10.1186/1471-244X-3-9
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Characteristics of Patient and Control Samples
| Patients | Controls | Group Difference | |||
| Age (years) | 34.8 | 7.2 | 36.6 | 6.8 | t(38) = 0.81, p > .1 |
| WRAT-R IQ | 102.7 | 10.6 | 105.4 | 8.9 | t(38) = 0.85, p > .1 |
| WAIS-R IQ | 87.6 | 8.2 | 105.9 | 10.8 | t(38) = 6.04, p < .001 |
| Digit span: Total | 13.2 | 3.4 | 18.3 | 4.3 | t(38) = 3.81, p < .001 |
| Digit span: Forward | 7.1 | 1.8 | 9.2 | 2.4 | t(38) = 3.03, p < .01 |
| Digit span: Backward | 6.1 | 2.3 | 9.1 | 2.5 | t(38) = 4.02, p < .001 |
| Neuroleptic medication | 19 | 0 | |||
| clozapine/olanzapine | 14 | - | |||
| risperidone | 7 | - | |||
| high potency drug* | 1 | - | |||
| anticholinergics | 1 | - | |||
| adjunctives** | 10 | - | |||
* = haloperidol ** = lithium, depakote, sertraline, lorazepam, venlafaxine, clonazepam, buspirone
Mean Numbers and Standard Deviations of Action and Evaluation Errors in Trials 1-5 and 6-10 in Patients and Controls
| Patients | Controls | |||||||
| Trials 1–5 | Trials 6–10 | Trials 1–5 | Trials 6–10 | |||||
| Action errors | ||||||||
| Omissions | 1.70 | 1.45 | 1.45 | 1.82 | .25 | .55 | .15 | .37 |
| Repetitions | .45 | 1.19 | .65 | 1.27 | .45 | .60 | .60 | 1.14 |
| Evaluation errors | ||||||||
| Action-no/ Report-yes | .75 | 1.21 | .60 | 1.39 | .10 | .31 | .10 | .31 |
| Action-yes/ Report-no | .10 | .31 | .20 | .52 | .10 | .31 | .05 | .22 |